esperoct powder for solution
novo nordisk canada inc - antihemophilic factor viii (recombinant, b-domain truncated), pegylated - powder for solution - 1500unit - antihemophilic factor viii (recombinant, b-domain truncated), pegylated 1500unit - hemostatics
esperoct powder for solution
novo nordisk canada inc - antihemophilic factor viii (recombinant, b-domain truncated), pegylated - powder for solution - 2000unit - antihemophilic factor viii (recombinant, b-domain truncated), pegylated 2000unit - hemostatics
esperoct powder for solution
novo nordisk canada inc - antihemophilic factor viii (recombinant, b-domain truncated), pegylated - powder for solution - 3000unit - antihemophilic factor viii (recombinant, b-domain truncated), pegylated 3000unit - hemostatics
oro min remineralizing soln liquid
germiphene corporation - potassium (potassium chloride); magnesium (magnesium chloride); fluoride (sodium fluoride); sodium phosphate dibasic; sodium phosphate (tribasic); calcium (calcium chloride); sodium (sodium chloride) - liquid - 0.0005%; 0.0003%; 0.02%; 0.505%; 2.318%; 0.129%; 0.623% - potassium (potassium chloride) 0.0005%; magnesium (magnesium chloride) 0.0003%; fluoride (sodium fluoride) 0.02%; sodium phosphate dibasic 0.505%; sodium phosphate (tribasic) 2.318%; calcium (calcium chloride) 0.129%; sodium (sodium chloride) 0.623% - dental agents
teeth desensitizing and remineralizing gel- potassium nitrate,sodium fluoride,sodium monofluorophosphate paste
fuzhou difeng bio-tech co., ltd. - potassium nitrate 5% sodium fluoride 0.15%, .antihypersensitivity .anticavity - to relieve the discomfort from teeth sensitivity caused by thermal, chemical changes, periodontal conditions...etc. aids in the prevention of dental cavities.
nctf 135®
sodium hyaluronate, nctf polyrevitalizing solution (composed of 12 vitamins, 6 minerals, 5 nucleic acids, 23 amino acids, 6 coenzymes) -
plaque refresh remineralizing rinse fresh mint- sodium fluoride liquid
tja health llc - sodium fluoride (unii: 8zyq1474w7) (fluoride ion - unii:q80vpu408o) - aids in the prevention of dental cavities
hyqvia
takeda israel ltd - human normal immunoglobulin - solution for infusion - human normal immunoglobulin 100 mg / 1 ml - immunoglobulins, normal human, for intravascular adm. - replacement therapy in adults, children and adolescents (0-18 years) in:• primary immunodeficiency syndromes with impaired antibody production • hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (cll), in whom prophylactic antibiotics have failed or are contra-indicated.• hypogammaglobulinaemia and recurrent bacterial infections in multiple myeloma (mm) patients.• hypogammaglobulinaemia in patients pre- and post-allogeneic hematopoietic stem cell transplantation (hsct).
hyqvia
baxalta innovations gmbh - human normal immunoglobulin - immunologic deficiency syndromes - immune sera and immunoglobulins, - replacement therapy in adults, children and adolescents (0-18 years) in:primary immunodeficiency syndromes with impaired antibody production.hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia (cll), in whom prophylactic antibiotics have failed or are contra‑indicated.hypogammaglobulinaemia and recurrent bacterial infections in multiple myeloma (mm) patients.hypogammaglobulinaemia in patients pre‑ and post‑allogeneic hematopoietic stem cell transplantation (hsct).
proleukin
novartis new zealand ltd - aldesleukin 18 miu (interleukin-2 (recombinant human)); - powder for injection - 18 miu - active: aldesleukin 18 miu (interleukin-2 (recombinant human)) excipient: dibasic sodium phosphate dihydrate mannitol monobasic sodium phosphate dihydrate sodium laurilsulfate - proleukin is indicated for the treatment of metastatic renal cell carcinoma (mrcc).